Renal clear cell carcinoma circRNA biomarker, screening method and diagnostic kit
A technology of clear cell renal cell carcinoma and biomarkers, applied in biochemical equipment and methods, DNA/RNA fragments, biostatistics, etc., can solve problems such as circRNA biomarkers of clear cell renal cell carcinoma that have not been discovered, and achieve good agreement sexual effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0045] Example 1 Analysis of circRNA expression profile in renal clear cell carcinoma
[0046] (1) Serum samples collected from patients with clear cell renal cell carcinoma
[0047] After obtaining the informed consent of the patients, 6 ml of early morning fasting venous blood was collected from 6 patients with clear cell renal cell carcinoma and 4 healthy subjects with clear pathological diagnosis in the First Affiliated Hospital of Zhejiang University in Zhejiang Province from April 2018 to May 2018 (as a control) . All patients with clear cell renal cell carcinoma were diagnosed for the first time, and had not undergone surgery, radiotherapy or chemotherapy before blood collection. The 4 healthy control groups were age-matched healthy people without malignant tumors or other diseases.
[0048] (2) Serum sample collection and processing
[0049] Draw 6ml of fasting venous blood in the morning and put it in a tube without anticoagulant, let it stand for 30 minutes, centr...
Embodiment 2
[0052] Example 2 Preliminary screening of target circRNA
[0053] (1) Collection of tissue samples from patients with clear cell renal cell carcinoma
[0054] After obtaining the patient’s informed consent, 6 pairs of postoperative specimens were collected from the First Affiliated Hospital of Zhejiang University in Zhejiang Province from April 2018 to May 2018, which were confirmed by pathology as clear cell renal cell carcinoma, including cancer tissue samples and paired distance cancer tissues 3 None of the patients had received chemotherapy and radiotherapy before surgery. All tissue samples were packed into RNase-free EP tubes and stored in a -80°C refrigerator.
[0055] 2. Extraction of total RNA from tissue samples
[0056] Specific steps are as follows:
[0057] ⑴Weigh the cut tissue with a weight between 0.3-0.5g, add 1ml AG RNAex Pro Reagent (Aikerui Bioengineering Co., Ltd.) lysate, and add magnetic beads, use a tissue disruptor to break the tissue, and homogeniz...
Embodiment 3
[0088] Example 3 Clinical small sample verification of target circRNA
[0089] 1. Collection of clinical samples
[0090] The present invention selects 7 pairs of clear cell renal cell carcinoma and paracancerous tissue samples, they come from 7 clear cell renal cell carcinoma patients respectively, selects the serum of 6 cases of healthy controls and 8 cases of clear cell renal cell carcinoma, and the samples of clear cell renal cell carcinoma tissue The collection and storage of samples are the same as in Example 2, and the collection and storage of serum samples are the same as in Example 1.
[0091] 2. Extraction of total RNA
[0092] The extraction of total RNA from renal clear cell carcinoma tissue samples was the same as in Example 2.
[0093] The extraction steps of total RNA from serum samples are as follows:
[0094] (1) Prepare 500 μl of thawed serum sample, add 2500 μl of AG RNAex Pro Reagent lysis reagent, mix well in a vortex shaker or upside down several time...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com